C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2002
11/28/2002	US20020177204 Geranylgeranyl pyrophosphate synthases
11/28/2002	US20020177203 Alpha2 subunit of prolyl 4-hydroxylase
11/28/2002	US20020177200 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
11/28/2002	US20020177198 Generation of ascorbic acid intermediates; cells, incubate with carbon source, incubate with enzymes, recover ascorbic acid intermediates
11/28/2002	US20020177197 Generation of ascorbic acid intermediates; cells, incubate with carbon source, incubate with enzymes, recover ascorbic acid intermediates
11/28/2002	US20020177195 Production of human mutated proteins in human cells by means of homologous recombination
11/28/2002	US20020177194 Polypeptide for use in the treatment of immunological, allergies and autoimmune diseases
11/28/2002	US20020177189 Novel fluorescent proteins
11/28/2002	US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002	US20020177185 Production of adenine nucleotide translocator (ant), novel ant lgands and screening assays therrfor
11/28/2002	US20020177177 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays
11/28/2002	US20020177164 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177162 Detection of receptor agonist; obtain sample containing receptor, incubate with modulator, monitor signal from receptor
11/28/2002	US20020177160 Method of increasing complementarity in a heteroduplex
11/28/2002	US20020177158 Detection of preferential protein in sample; obtain pool of proteins, incubate with probe, detect signal from probe, recover proteins
11/28/2002	US20020177155 Normalized nucleic acid libraries and methods of production thereof
11/28/2002	US20020177147 Mdr1 variants and methods for their use
11/28/2002	US20020177145 Detection and classification of nervous system progenitor cells; obtain tissue, monitor expression of daedalos protein in sample, compare to control, ampified daedalos expression indicates presence of nervous system progenitor cells
11/28/2002	US20020177143 Non-alloying core shell nanoparticles
11/28/2002	US20020177140 Compositions and methods relating to prostate specific genes and proteins
11/28/2002	US20020177139 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
11/28/2002	US20020177137 Detecting preferential nucleotide sequences in pool of sequences; obtain nucleotide sequences, deposit on substrate, incubate with probe, detect signal, which indicates, presencec of preferential sequences
11/28/2002	US20020177134 Expression vector for use in the generation of animal models for use as tools in gene therapy
11/28/2002	US20020177133 Template-dependent ligation with PNA-DNA chimeric probes
11/28/2002	US20020177131 Identifying a base in a nucleic acid
11/28/2002	US20020177129 Determination of sequence of preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, polymerase and chain termination nucleotide, determine nucleotide sequence
11/28/2002	US20020177127 Compositions and methods for detecting human immunodeficiency virus 2 (HIV-2)
11/28/2002	US20020177125 Polypeptide for use in the treatment of viral disease
11/28/2002	US20020177124 Nucleotide sequences coding polypeptide for use in the detection, prevention and diagnosis viral diseases
11/28/2002	US20020176870 Methods and compositions useful for stimulating an immune response
11/28/2002	US20020176869 Hepatitus A virus vaccines
11/28/2002	US20020176868 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same
11/28/2002	US20020176867 Fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues, and the vaccine based on fusion protein, which induces efficient immunological memory
11/28/2002	US20020176864 Two-domain MHC polypeptides include MHC( major histocompatibility complex) class II-based molecules that covalently linked beta 1 and alpha 1 domains, and MHC class I-based molecules that covalently linked alpha-1 and alpha-2
11/28/2002	US20020176856 Administering an antibody to the mammal, that binds with a specified target epitope of an antigen, associated with a tumor or an infectious agent; having engineered glycosylation site in the constant region of the heavy chain antibodies
11/28/2002	US20020176852 Mitogenic oxygenase regulators
11/28/2002	US20020176851 Aministering to mammal an effective amount of therapeutic cells, expressing a membrane-bound, proteinaceous chimeric receptor, capable recognizing and binding target cell or infective agent; antitumor therapy
11/28/2002	US20020176848 Antimicrobial mediated bacterial DNA delivery
11/28/2002	US20020176847 Administering to a mammal viral vectors for treating and preventing atherosclerosis, osteoporosis, cardiovascular disease, Alzheimer's disease, diabetes mellitus, infectious diseases, cancer, and inherited disorders
11/28/2002	US20020176820 Functional expression of, and assay for, functional cellular receptors in vivo
11/28/2002	US20020176805 For DNA staining and analysis
11/28/2002	US20020176796 Illuminating platelet compositions without completely damaging antigens, enzymes and membrane functions
11/28/2002	US20020174660 Thin-film thermoelectric cooling and heating devices for DNA genomic and proteomic chips, thermo-optical switching circuits, and IR tags
11/28/2002	DE10162176A1 Simultaneous, position-specific cleavage of DNA, useful e.g. for cutting out gene segments, using hybridizing sequence linked to nanoparticle that responds to irradiation
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins
11/28/2002	DE10123133A1 New proteins binding specifically to the ED-b fibronectin domain, are cell adhesion and proliferation mediators useful e.g. in screening tests
11/28/2002	DE10123041A1 New single-chain human antibody fragment, useful for treating or diagnosing hepatitis C virus infection, has affinity for an essential viral protein
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	DE10119203A1 Verfahren zur Erzeugung von doppelsträngigen Nukleinsäuren mit einzelsträngigen Überhängen beliebiger Länge und Nukleotidzusammensetzung A process for the production of double stranded nucleic acids with single-stranded overhangs of arbitrary length and nucleotide composition
11/28/2002	CA2755964A1 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
11/28/2002	CA2453579A1 Methods and compositions using genetic package display
11/28/2002	CA2450677A1 A novel intein and uses thereof
11/28/2002	CA2448668A1 Modulation of cd200 receptors
11/28/2002	CA2448505A1 Compositions and methods for use in isolation of nucleic acid molecules
11/28/2002	CA2448253A1 Human cdnas and proteins and uses thereof
11/28/2002	CA2448186A1 Novel smg-1
11/28/2002	CA2448145A1 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002	CA2448132A1 Vectors for enhanced expression of vegf for disease treatment
11/28/2002	CA2448120A1 Muscle-specific expression vectors
11/28/2002	CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002	CA2448097A1 N4 virion single-stranded dna dependent rna polymerase
11/28/2002	CA2448092A1 Internalisation of virus into cells
11/28/2002	CA2448031A1 Method for stabilising of nucleic acids
11/28/2002	CA2448018A1 Compositions and methods for inhibiting metastasis
11/28/2002	CA2448014A1 Tsg101 as inhibitor of hiv production
11/28/2002	CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002	CA2447948A1 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof
11/28/2002	CA2447942A1 A gene and uses therefor
11/28/2002	CA2447933A1 A repressor-mediated regulation system for control of gene expression in plants
11/28/2002	CA2447799A1 Emission ratiometric indicators of phosphorylation
11/28/2002	CA2447797A1 Protease deficient caulobacter host cells
11/28/2002	CA2447793A1 Immunostimulatory oligodeoxynucleic molecules
11/28/2002	CA2447706A1 Double selection cloning method and vectors therefor
11/28/2002	CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002	CA2447616A1 Vaccine composition
11/28/2002	CA2447612A1 Selection of target sites for antisense attack of rna
11/28/2002	CA2447598A1 Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
11/28/2002	CA2447340A1 Kinases and phosphatases
11/28/2002	CA2447338A1 Receptors and membrane-associated proteins
11/28/2002	CA2447313A1 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/28/2002	CA2447240A1 Method for the synthesis of dna sequences
11/28/2002	CA2447070A1 Methods for predicting the activities of cellular constituents
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2446398A1 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	CA2445972A1 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2443437A1 Antibodies specific for cd44v6
11/28/2002	CA2443342A1 Mage-a3 peptides presented by hla class ii molecules
11/28/2002	CA2443258A1 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	CA2441666A1 Phytases, nucleic acids encoding them and methods and using them
11/28/2002	CA2440368A1 Staphylococcus aureus proteins and nucleic acids
11/28/2002	CA2438597A1 Champ - a cardiac helicase-like factor
11/28/2002	CA2434323A1 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/27/2002	WO2001094575A1 Dna sequence regulating plant fruit-specific expression
11/27/2002	EP1260927A2 Information processing system using nucleotide sequence-related information
11/27/2002	EP1260597A2 Process for labeling a nucleic acid, including purification, and labeled RNA fragments obtained by this process
11/27/2002	EP1260596A2 Process for labeling a ribonucleic acid, including optional signal amplification, and labeled RNA fragments which are obtained by this process
11/27/2002	EP1260595A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260586A2 Method and reagent for inhibiting the expression of disease related genes

1 ... 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 ... 4023